Physician profile
Paul Yang
NPI 1245658772
$59,885.73
in general payments reported to CMS, 2019-2025
10 companies · $248 in 2025
The $248 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $57K · 2021: $23.13 · 2022: $95.43 · 2023: $56.64 · 2024: $2,337 · 2025: $248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $540 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $539.55 |
| Education | $101.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $56,593.00 | 2020-2024 | Real Intelligence |
| Think Surgical, INC. | $2,000.00 | 2024 | |
| Medical Device Business Services, INC. | $609.60 | 2019 | |
| Stryker Corporation | $358.18 | 2019-2025 | Triathlon, Insignia, Restoration |
| Zimmer Biomet Holdings, INC. | $171.91 | 2024-2025 | Avenir, Rosa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.83 | 2025 | Lifevest |
| Integra Lifesciences Corporation | $44.87 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medacta USA, INC. | $23.45 | 2022 | |
| Ethicon US, LLC | $20.66 | 2025 | Ethicon, Vistaseal |
| Sanofi-Aventis U.S. LLC | $18.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.